Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT04474457
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients, diagnosed with Covid-19 disease who are 15 years of age or older at the time of enrollment
* Patients who have understood all study procedures that will be applied under the study protocol
* Patients with confirmed diagnosis of COVID-19 by PCR and/or other accepted methods and have a treatment decision with favipiravir
* Patients who will accept oropharyngeal sample and venous blood sample collection periodically within the scope of the study protocol
Exclusion Criteria:
* Patients who are pregnant or females who are breast feeding
* Patients under the age of 15
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT04474457
Study Brief:
Protocol Section:
NCT04474457